UT Health Houston

Gastrointestinal, Hepatic, and Pancreatobiliary Surgical Pathology Fellowship Program Openings for 2026 and 2027
Number of appointments per year: 1

Description: The Department of Pathology offers a one-year fellowship program for the advanced study of neoplastic and non-neoplastic diseases of the gastrointestinal tract. This includes native and transplant hepatopathology, diseases of the gallbladder, biliary tract, and pancreas in both adult and pediatric patients. Our department is devoted to teaching, and the fellow is to participate in clinical conferences, housestaff, and medical student education. The fellowship training includes the use of modern molecular biology techniques, and participation in research is strongly encouraged. There are multiple opportunities to work with our faculty members on projects. The department will provide funding and one-week time off for the fellow to attend a national conference.

Our medical school and clinical campus is within The Texas Medical Center (TMC) with over 60 patient care, basic biomedical sciences, and translational research facilities. The TMC campus between Rice University, Hermann Park, and Brays Bayou constitutes the largest medical center in the world. The fellow has constant access to research talks and symposiums. Our clinical work includes tissue biopsies and resection specimens from patients at UTHealth, Memorial Hermann Hospital, Children’s Memorial Hermann, and Lyndon B. Johnson Hospital. In addition, the fellow will have an opportunity to spend a one-month elective at the MD Anderson Cancer Center.

Curriculum: The fellowship begins on July 1st and ends on June 30th of the following year. The fellow will supervise PA and resident grossing, preview slides, construct pathology reports, have cooperative learning with the attending pathologist, take an active role in intraoperative consultations, participate in clinical-pathological conferences and tumor boards. The fellow has the potential for independent sign-out privileges (see requirements below).

Requirements: Candidate must be board certified or eligible for certification in Anatomic Pathology (AP) or AP/Clinical Pathology (CP). Applicants must have completed their AP training and be AP Board eligible/certified by the July start date. Applicants must be a U.S. citizen, have a permanent resident card, work authorization (EAD) or J-1 visa. If the fellow wishes for the opportunity of independent sign-out, a Texas medical license is required. The department will reimburse TMB license fees.

How to Apply and Supporting Documents: Accepting applications for academic year 2026-27; and 2027-28

• Statement of intent and a brief discussion about your interest in gastrointestinal pathology and long-term career plans.
• Curriculum vitae
• ECFMG certificate (if applicable)
• USMLE (passed within 3 attempts)
• Three letters of recommendation (1 from current program director, 2 from current attendings). These letters should be emailed directly to GI Fellowship Program Director Dr. Erin Rubin at Erin.Rubin@uth.tmc.edu separately by the persons making the recommendations.

Send the application and supporting documents (via email) to the attention of GI Fellowship Program Director Erin Rubin, MD. All application documents should be sent to Program Coordinator, Ms. Novate Creeks at Novate.Creeks@uth.tmc.edu

Stipends: Commensurate with the candidate’s level of training.

Faculty

• Erin Rubin, MD, Program Director
• Antonio Galvao Neto, MD
• Suhair Al-Salihi, MD
• Lei Sun, MD
• Rossana Kazemimood, MD

UTHealth is committed to providing equal opportunity in all employment-related activities without regard to race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, gender identity or expression, veteran status or any other basis prohibited by law or university policy. Reasonable accommodation, based on disability or religious observances, will be considered in accordance with applicable law and UTHealth policy. The University maintains affirmative action programs with respect to women, minorities, individuals with disabilities, and eligible veterans in accordance with applicable law.